5 results  1 of 1 

1 Combined estrogen-progestin pill is a safe and effective option for endometrial hyperplasia without atypia: a three-year single center experience
Yang Wang, Victoria Nisenblat, Liyuan Tao, XinYu Zhang, Hongzhen Li, Caihong Ma
J Gynecol Oncol.2019;30(3):e49.  Published online 2019 January 28     DOI: http://dx.doi.org/10.3802/jgo.2019.30.e49
      
2 Fertility-preserving treatment in complex atypical hyperplasia and early endometrial cancer in young women with oral progestin: Is it effective?
Ji Sun Baek, Wan Ho Lee, Woo Dae Kang, Seok Mo Kim
Obstet Gynecol Sci.2016;59(1):24-31.   Published online 2016 January 15     DOI: http://dx.doi.org/10.5468/ogs.2016.59.1.24
      
3 Therapeutic options for management of endometrial hyperplasia
Vishal Chandra, Jong Joo Kim, Doris Mangiaracina Benbrook, Anila Dwivedi, Rajani Rai
J Gynecol Oncol.2016;27(1):e8.  Published online 2015 December 1     DOI: http://dx.doi.org/10.3802/jgo.2016.27.e8
      
4 Fertility-sparing treatment of endometrial cancer: options, outcomes and pitfalls
Joshua P. Kesterson, James Fanning
J Gynecol Oncol.2012;23(2):120-124.   Published online 2012 April 3     DOI: http://dx.doi.org/10.3802/jgo.2012.23.2.120
      
5 A Successful Live Birth Through in vitro Fertilization Program After Conservative Treatment of FIGO Grade I Endometrial Cancer
Joon-Cheol Park, Chi-Hum Cho, Jeong-Ho Rhee
J Korean Med Sci.2006;21(3):567-571.   Published online 2006 June 21     DOI: http://dx.doi.org/10.3346/jkms.2006.21.3.567
      

 1 of 1